ENDRA Life Sciences (NDRA) Invested Capital (2016 - 2021)
Historic Invested Capital for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $13.2 million.
- ENDRA Life Sciences' Invested Capital rose 29448.69% to $13.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $13.2 million, marking a year-over-year increase of 29448.69%. This contributed to the annual value of $7.8 million for FY2020, which is 6338.7% up from last year.
- Latest data reveals that ENDRA Life Sciences reported Invested Capital of $13.2 million as of Q3 2021, which was up 29448.69% from $15.0 million recorded in Q2 2021.
- Over the past 5 years, ENDRA Life Sciences' Invested Capital peaked at $17.9 million during Q1 2021, and registered a low of -$1.4 million during Q1 2017.
- In the last 5 years, ENDRA Life Sciences' Invested Capital had a median value of $3.8 million in 2019 and averaged $5.4 million.
- Its Invested Capital has fluctuated over the past 5 years, first plummeted by 10638.43% in 2018, then soared by 143446.68% in 2021.
- Over the past 5 years, ENDRA Life Sciences' Invested Capital (Quarter) stood at $5.3 million in 2017, then rose by 18.44% to $6.2 million in 2018, then dropped by 23.81% to $4.8 million in 2019, then skyrocketed by 63.39% to $7.8 million in 2020, then surged by 69.14% to $13.2 million in 2021.
- Its Invested Capital was $13.2 million in Q3 2021, compared to $15.0 million in Q2 2021 and $17.9 million in Q1 2021.